{'fraction_non_alphanumeric': 0.03170028818443804, 'fraction_numerical': 0.005763688760806916, 'mean_word_length': 5.435185185185185, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Insulin-like factor of growth (IGFI), insulin-like growth factor binding protein 3 (IGFBP3) and transforming growth factor beta1 (TGF-beta1) in patients with locally-advanced and metastatic cancer of prostate].

The paper deals with a study of growth factors in blood serum from patients with locally-advanced and metastatic cancer of prostate prior to treatment. Twelve months after diagnosis was made, the data were compared with the initial indices. Immunoenzymatic assay was used in combination with the existing standard procedures of examination of cancer patients. Data were compared with clinico-morphological and serologic evidence on tumor process using medico-biological statistics.